Thursday, August 27, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
TRADE & TARIFFSTrump's 50% Canada Tariffs Take Effect—Retailers BracetodayDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Largest Defense IT Overhaul in Years4 weeks agoTRADE & TARIFFSU.S. Rolls Out Iran Sanctions—Oil Prices SliptodayDEFENSERocket Lab Wins $266M Space Force Contract—Suborbital Launch Capability Becomes Defense Asset4 weeks agoHEALTHCARE & FDAAbbott's Dual Glucose-Ketone Monitor Wins FDA NodyesterdayHEALTHCARE & FDACMS Overhauls Medicare Advantage Star Ratings—Big Insurers Win, Quality Metrics Tighten4 weeks agoHEALTHCARE & FDARegeneron's Gene Therapy Wins First GSD Type Ia ApprovalyesterdayDEFENSERocket Lab Wins $266M Space Force Missile Defense Contract—Suborbital Launch Niche Gets Federal Validation4 weeks agoDEFENSEStryker Lands $100M Defense Contract—Combat Vehicle BoostyesterdayDEFENSEPentagon Awards Oracle $7B Software Consolidation Deal—Cloud Incumbents Face Pressure, Oracle Locks in Defense Revenue4 weeks agoTRADE & TARIFFSWalmart Deploys $2.9B Tariff Refund Into Price CutsyesterdayCRYPTOSEC Settles Coinbase FOIA Suit Over Missing Gensler Texts—Crypto Compliance Pressure Eases, Coinbase Stock Gains Clarity4 weeks agoTRADE & TARIFFSTrump Lifts Ground Beef Tariffs—Ranchers Face Price PressureyesterdayHEALTHCARE & FDACMS Stars Redo Lifts Medicare Advantage Insurers—Rating System Overhaul Favors UnitedHealth, Humana, Anthem4 weeks agoWHITE HOUSETrump Kills Affirmative Action Rules—Contractors Face Compliance Shift2 days agoDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue4 weeks agoHEALTHCARE & FDAFDA Clears Robotic Blood Draw—Phlebotomy Shortage Eases2 days agoDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue4 weeks agoWHITE HOUSELabor Dept Eases Disability Hiring Rules—Contractors Save Compliance Costs2 days agoMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue4 weeks agoWHITE HOUSELabor Dept Eases Veteran Hiring Rules—Contractors Cut Compliance2 days agoENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors4 weeks agoTECHCHIPS Act Transforms Binghamton Into Semiconductor Hub3 days agoSEARCH DEMANDCasgevy List Price: $2.2 Million4 weeks agoTRADE & TARIFFSTrump Administration Targets Iran's Banking System With New Sanctions3 days agoSEARCH DEMANDData Center Power Exchange4 weeks agoTECHUtah Governor Signs Quantum Computing Initiative Order3 days agoTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on Windfall4 weeks agoDEFENSEFAA Engine Inspection Order Lifts MRO Stocks4 days agoTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal Backing4 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings4 days agoHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win4 weeks agoHEALTHCARE & FDATrump Vaccine Spacing Order Reshapes Pharma Demand4 days agoDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in Revenue4 weeks agoTECHD-Wave Wins Canadian Quantum Funding for Annealing4 days agoWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected Market4 weeks agoENERGYEnbridge Wins Federal Permit for Line 5 Tunnel5 days agoHEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan Disruption4 weeks agoENERGYFederal Court Orders Enbridge Line 5 Removal5 days agoENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk3 weeks agoWHITE HOUSEFinCEN Finalizes BOI Exemption for U.S. Persons5 days agoTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze3 weeks agoHEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice Overpayment6 days agoHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win3 weeks agoENERGYNewsom Passes Diablo Canyon Decision to Successorlast weekHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure3 weeks agoDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervaluedlast weekHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief3 weeks agoTECHCommerce Eases Drone Export Rules—U.S. Makers Winlast weekTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone3 weeks agoHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnosticslast weekDEFENSERising Defense Spending Lifts Northrop Grumman Outlook3 weeks agoHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopolylast weekMARKETSFTC Threatens Booking Holdings Over Priceline Practices3 weeks agoDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfalllast weekHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices3 weeks agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Easeslast weekHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma3 weeks agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demandlast weekTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payout3 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressurelast weekTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backing3 weeks agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boostlast weekWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employers3 weeks agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Pathlast weekENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakes3 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earningslast weekDEFENSEPentagon Awards Space-Based Target Tracking Contracts3 weeks agoCRYPTOSEC Delays Crypto Rules—Uncertainty Persistslast weekTECHTrump Administration Adds 6 Chipmakers to U.S. Portfolio3 weeks agoTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refundlast weekWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertainty2 weeks agoTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makerslast weekDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gains2 weeks agoHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Winslast weekWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shift2 weeks agoDEFENSEBlackSky Lands Multi-Year Satellite Contractlast weekWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacing2 weeks agoTECHFCC Eases Broadband Label Rules—ISPs Win Flexibility2 weeks agoHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidance2 weeks agoDEFENSEIonQ Lands $28M U.S. Defense Quantum Contract2 weeks agoENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Cask2 weeks agoHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestock2 weeks ago
That's your last free article this week. Create a free account for 4 a week — or go Pro for everything.Go Pro →
Trade & Tariffs

DeepSeek's Custom Chip Gambit Is a Direct Threat to Nvidia's China Revenue — and a Warning for AMD

If DeepSeek successfully builds around U.S. export controls with domestic silicon, it removes the largest remaining China demand driver for American AI chip companies.

Image: Money Racket
1-YEAR MOVE
+536% −10%
NVDA ▲7.9% AMD ▲151.7% INTC ▲249.2% MU ▲468.4%
1-year price move by ticker
TickerCompany1-year change
NVDANvidia+7.9%
AMDAdvanced Micro Devices+151.7%
INTCIntel+249.2%
MUMicron+468.4%

DeepSeek is reportedly pursuing a custom chip strategy designed to bypass U.S. semiconductor export sanctions, according to Barron's. The move signals that China's most capable AI lab is no longer waiting for workarounds to access Nvidia hardware — it's trying to eliminate the dependency entirely.

DeepSeek building its own chip isn't just a competitive move — it's an attempt to make Nvidia permanently irrelevant to China's AI buildout.

Who's exposed: Nvidia NVDA has already lost direct H100/H800 sales to China under export controls, but the company still benefits indirectly when Chinese firms find ways to access chips through third-party channels. A successful domestic Chinese AI chip ecosystem — anchored by a credible lab like DeepSeek — reduces that residual demand and signals to other Chinese AI developers that U.S. chips are not necessary. Advanced Micro Devices AMD faces the same dynamic: its MI300X accelerator has been positioned as an alternative for markets where Nvidia is restricted, but a self-sufficient Chinese AI stack removes AMD from the equation too.

Who cashes in: U.S. chip equipment companies with limited China exposure benefit from the narrative that export controls are working — Lam Research LRCX, KLA Corporation KLAC, and Applied Materials AMAT have already been partially restricted from China and have been diversifying revenue. A world where China builds its own AI chips still requires semiconductor manufacturing equipment, though at lower technology nodes than U.S. firms can supply. Domestically, the DeepSeek threat reinforces the case for CHIPS Act investment in U.S. fabs — a tailwind for Intel INTC and Micron MU as the policy rationale for subsidies strengthens.

Watch whether DeepSeek's custom chip achieves meaningful training performance at scale — that's the technical gate. If it does, Nvidia's China revenue story changes permanently. If it underperforms, the threat remains theoretical and Nvidia's export-control-era positioning holds.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/deepseek-custom-chip-nvidia-export-controls-amd-risk/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo